CG Oncology, Inc. Common stock Financial Flexibility Index
CG Oncology, Inc. Common stock financial flexibility index. CG Oncology, Inc. Common stock (CGON) has a Financial Flexibility Index of -0.93x as of December 2025. Free cash flow of $-36.21 Million (operating CF $-36.22 Million minus capex $7.00K) represents -1% of total liabilities ($38.99 Million). Check how resilient are CG Oncology, Inc. Common stock's assets to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of CG Oncology, Inc. Common stock (2021–2025)
Financial flexibility index of CG Oncology, Inc. Common stock from 2021 to 2025. Historical Financial Flexibility Index trend for CG Oncology, Inc. Common stock across 5 annual periods. Explore CGON operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
CG Oncology, Inc. Common stock Financial Flexibility Index by Year (2021–2025)
CG Oncology, Inc. Common stock financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for CG Oncology, Inc. Common stock. For the full cash flow conversion analysis, see CG Oncology, Inc. Common stock cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.39x | $-132.21 Million | $-132.35 Million | $38.99 Million | ▲ +7.4% |
| 2024 | -3.66x | $-78.48 Million | $-78.71 Million | $21.42 Million | ▼ -16.4% |
| 2023 | -3.15x | $-45.68 Million | $-45.68 Million | $14.51 Million | ▼ -138.5% |
| 2022 | -1.32x | $-29.79 Million | $-29.80 Million | $22.57 Million | ▼ -79.5% |
| 2021 | -0.74x | $-13.56 Million | $-13.65 Million | $18.44 Million | — |